Wednesday - October 29, 2025
UNC Lab Contributed to FDA Approval of First-of-its-Kind Medication for Pediatric Brain Tumor
September 24, 2025
CHAPEL HILL, North Carolina, Sept. 24 -- The University of North Carolina School of Medicine issued the following news:

* * *

UNC Lab Contributed to FDA Approval of First-of-its-Kind Medication for Pediatric Brain Tumor

Experts at the UNC School of Medicine played a pivotal role in the approval of a new medication for pediatric patients that could also be used to treat other types of cancer.

*

Diffuse midline glioma, a type of rar . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products